Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III Sells 1,368 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,368 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $60.08, for a total transaction of $82,189.44. Following the sale, the chief executive officer now directly owns 41,129 shares of the company’s stock, valued at approximately $2,471,030.32. This trade represents a 3.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $63.01, for a total transaction of $126,020.00.

Kewaunee Scientific Trading Down 4.4 %

KEQU stock opened at $55.20 on Tuesday. The firm has a fifty day moving average price of $48.78 and a 200 day moving average price of $45.11. Kewaunee Scientific Co. has a fifty-two week low of $27.00 and a fifty-two week high of $67.20. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The firm has a market cap of $158.53 million, a PE ratio of 8.75 and a beta of 0.72.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. grew its holdings in shares of Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after purchasing an additional 900 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares in the last quarter. Ritholtz Wealth Management grew its holdings in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after purchasing an additional 2,156 shares in the last quarter. Barclays PLC purchased a new position in shares of Kewaunee Scientific in the third quarter valued at $121,000. Finally, Heron Bay Capital Management purchased a new position in shares of Kewaunee Scientific in the second quarter valued at $252,000. 32.69% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.